VU University Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2022

  1. A new oxadiazole-based topsentin derivative modulates cyclin-dependent kinase 1 expression and exerts cytotoxic effects on pancreatic cancer cells

    Molecules, Vol. 27, Núm. 1

2011

  1. Antiproliferative effects of novel aliphatic acetogenin analogs against aggressive solid tumor cell lines

    In Vivo, Vol. 25, Núm. 2, pp. 203-207

2008

  1. CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo

    Oncology Reports, Vol. 19, Núm. 6, pp. 1517-1523

2007

  1. Mechanisms of action of FdUMP[10]: Metabolite activation and thymidylate synthase inhibition

    Oncology Reports, Vol. 18, Núm. 1, pp. 287-291

2006

  1. Cytotoxicity of sphingoid marine compound analogs in mono- and multilayered solid tumor cell cultures

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 195-202

2004

  1. Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2′-2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000

    Biochemical Pharmacology, Vol. 68, Núm. 4, pp. 601-609

2001

  1. Synthesis and in vitro cytotoxicity of novel long chain busulphan analogues

    Bioorganic and Medicinal Chemistry Letters, Vol. 11, Núm. 6, pp. 861-863

1999

  1. Selective cell kill of the combination of gemcitabine and cisplatin in multilayered postconfluent tumor cell cultures

    Anti-Cancer Drugs, Vol. 10, Núm. 5, pp. 445-452

  2. Synthesis, in vitro cytotoxicity and in vivo anti-inflammatory activity of long chain 3-amino-1,2-diols

    Bioorganic and Medicinal Chemistry Letters, Vol. 9, Núm. 6, pp. 821-826